Blood Products, Volume Control, and Renal Support in the Coagulopathy of Liver Disease

Stanworth, 2004, Is fresh frozen plasma clinically effective?, Br J Haematol, 126, 139, 10.1111/j.1365-2141.2004.04973.x Holland, 2006, Should plasma be transfused prophylactically before invasive procedures?, Curr Opin Hematol, 13, 447, 10.1097/01.moh.0000245688.47333.b6 Holland, 2006, Toward rational fresh frozen plasma transfusion: the effect of plasma transfusion on coagulation test results, Am J Clin Pathol, 126, 1, 10.1309/NQXHUG7HND78LFFK Bux, 2007, The pathogenesis of transfusion-related acute lung injury (TRALI), Br J Haematol, 136, 788, 10.1111/j.1365-2141.2007.06492.x Kleinman, 2004, Toward an understanding of transfusion-related acute lung injury: statement of a consensus panel, Transfusion, 44, 1774, 10.1111/j.0041-1132.2004.04347.x Khan, 2007, Fresh-frozen plasma and platelet transfusions are associated with development of acute lung injury in critically ill medical patients, Chest, 131, 1308, 10.1378/chest.06-3048 Eder, 2007, Transfusion-related acute lung injury surveillance (2003–2005) and the potential impact of the selective use of plasma from male donors in the American Red Cross, Transfusion, 47, 599, 10.1111/j.1537-2995.2007.01102.x Gajic, 2007, Transfusion-related acute lung injury in the critically ill: prospective nested case-control study, Am J Respir Crit Care Med, 176, 886, 10.1164/rccm.200702-271OC Rana, 2006, Transfusion-related acute lung injury and pulmonary edema in critically ill patients: a retrospective study, Transfusion, 46, 1478, 10.1111/j.1537-2995.2006.00930.x Skeate, 2007, Distinguishing between transfusion related acute lung injury and transfusion associated circulatory overload, Curr Opin Hematol, 14, 682, 10.1097/MOH.0b013e3282ef195a Gajic, 2007, Transfusion from male-only versus female donors in critically ill recipients of high plasma volume components, Crit Care Med, 35, 1645, 10.1097/01.CCM.0000269036.16398.0D Silliman, 2007, High-volume transfusion from male-only versus female donor plasma and hypoxemia in the critically ill, Crit Care Med, 35, 1775, 10.1097/01.CCM.0000269939.69813.A8 Benjamin R. Transfusion-related acute lung injury (TRALI): immunologic issues regarding donors and patients. In: American Society for Apheresis Annual Meeting. 2006;Las Vegas (NV). Available at: http://www.apheresis.org/%7EDOCUMENTS/Wed_0815.5_Benjamin_Venetian_BC.pdf. Accessed December 12, 2007. MacLennan, 2006, Risks and side effects of therapy with plasma and plasma fractions, Baillieres Best Pract Res Clin Haematol, 19, 169, 10.1016/j.beha.2005.01.033 Tripodi, 2007, Review article: the prothrombin time test as a measure of bleeding risk and prognosis in liver disease, Aliment Pharmacol Ther, 26, 141, 10.1111/j.1365-2036.2007.03369.x Tripodi, 2006, Thrombin generation in patients with cirrhosis: the role of platelets, Hepatology, 44, 440, 10.1002/hep.21266 Bergqvist, 1979, The effect of normovolemic hemodilution on microvascular hemostasis in the rabbit, Res Exp Med, 175, 61, 10.1007/BF01851234 Turitto, 1980, Red blood cells: their dual role in thrombus formation, Science, 207, 541, 10.1126/science.7352265 Hathcock, 2006, Flow effects on coagulation and thrombosis, Arterioscler Thromb Vasc Biol, 26, 1729, 10.1161/01.ATV.0000229658.76797.30 Gines, 1988, Randomized comparative study of therapeutic paracentesis with and without intravenous albumin in cirrhosis, Gastroenterology, 94, 1493, 10.1016/0016-5085(88)90691-9 Gines, 1993, Incidence, predictive factors, and prognosis of the hepatorenal syndrome in cirrhosis with ascites, Gastroenterology, 105, 229, 10.1016/0016-5085(93)90031-7 Sort, 1999, Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis, N Engl J Med, 341, 403, 10.1056/NEJM199908053410603 Ortega, 2002, Terlipressin therapy with and without albumin for patients with hepatorenal syndrome: results of a prospective, nonrandomized study, Hepatology, 36, 941, 10.1053/jhep.2002.35819 Hadengue, 1992, Total effective vascular compliance in patients with cirrhosis: a study of the response to acute blood volume expansion, Hepatology, 15, 809, 10.1002/hep.1840150511 Moller, 1995, Effect of volume expansion on systemic hemodynamics and central and arterial blood volume in cirrhosis, Gastroenterology, 109, 1917, 10.1016/0016-5085(95)90759-9 Kiszka-Kanowitz, 2001, Blood volume distribution in patients with cirrhosis: aspects of the dual-head gamma-camera technique, J Hepatol, 35, 605, 10.1016/S0168-8278(01)00175-1 D'Amico, 2006, Hepatic vein pressure gradient reduction and prevention of variceal bleeding in cirrhosis: a systematic review, Gastroenterology, 131, 1611, 10.1053/j.gastro.2006.09.013 Kravetz, 1989, Hemodynamic effects of blood volume restitution following a hemorrhage in rats with portal hypertension due to cirrhosis of the liver: influence of the extent of portal-systemic shunting, Hepatology, 9, 808, 10.1002/hep.1840090603 Castaneda, 2001, Effects of blood volume restitution following a portal hypertensive-related bleeding in anesthetized cirrhotic rats, Hepatology, 33, 821, 10.1053/jhep.2001.23437 Zimmon, 1974, The portal pressure-blood volume relationship in cirrhosis, Gut, 15, 99, 10.1136/gut.15.2.99 Villanueva, 2001, Somatostatin treatment and risk stratification by continuous portal pressure monitoring during acute variceal bleeding, Gastroenterology, 121, 110, 10.1053/gast.2001.25536 Boyer, 1966, Effect of plasma-volume expansion on portal hypertension, N Engl J Med, 275, 750, 10.1056/NEJM196610062751403 Massicotte, 2004, Transfusion predictors in liver transplant, Anesth Analg, 98, 1245, 10.1213/01.ANE.0000111184.21278.07 Cirera, 1997, Anemia worsens hyperdynamic circulation of patients with cirrhosis and portal hypertension, Dig Dis Sci, 42, 1697, 10.1023/A:1018861415259 Elizalde, 1998, Effects of increasing blood hemoglobin levels on systemic hemodynamics of acutely anemic cirrhotic patients, J Hepatol, 29, 789, 10.1016/S0168-8278(98)80260-2 Tito, 1990, Total paracentesis associated with intravenous albumin management of patients with cirrhosis and ascites, Gastroenterology, 98, 146, 10.1016/0016-5085(90)91303-N Garcia-Compean, 1993, Total therapeutic paracentesis (TTP) with and without intravenous albumin in the treatment of cirrhotic tense ascites: a randomized controlled trial, Liver, 13, 233, 10.1111/j.1600-0676.1993.tb00637.x Luca, 1995, Beneficial effects of intravenous albumin infusion on the hemodynamic and humoral changes after total paracentesis, Hepatology, 22, 753 Evans, 2002, Albumin as a drug—biological effects of albumin unrelated to oncotic pressure, Aliment Pharmacol Ther, 16, 6, 10.1046/j.1365-2036.16.s5.2.x Planas, 1990, Dextran-70 versus albumin as plasma expanders in cirrhotic patients with tense ascites treated with total paracentesis. Results of a randomized study, Gastroenterology, 99, 1736, 10.1016/0016-5085(90)90481-F Fassio, 1992, Paracentesis with Dextran 70 vs. paracentesis with albumin in cirrhosis with tense ascites, J Hepatol, 14, 310, 10.1016/0168-8278(92)90176-P Sola, 1994, Total paracentesis with dextran 40 vs diuretics in the treatment of ascites in cirrhosis: a randomized controlled study, J Hepatol, 20, 282, 10.1016/S0168-8278(05)80070-4 Gines, 1996, Randomized trial comparing albumin, dextran 70, and polygeline in cirrhotic patients with ascites treated by paracentesis, Gastroenterology, 111, 1002, 10.1016/S0016-5085(96)70068-9 Van der Linden, 2006, The effects of colloid solutions on hemostasis, Can J Anaesth, 53, S30, 10.1007/BF03022250 Jones, 2003, The influence of crystalloid and colloid replacement solutions in acute normovolemic hemodilution: a preliminary survey of hemostatic markers, Anesth Analg, 96, 363, 10.1213/00000539-200302000-00012 Ekseth, 2002, The in vitro effects of crystalloids and colloids on coagulation, Anaesthesia, 57, 1102, 10.1046/j.1365-2044.2002.02782_1.x de Jonge, 2001, Effects of different plasma substitutes on blood coagulation: a comparative review, Crit Care Med, 29, 1261, 10.1097/00003246-200106000-00038 Mortier, 1997, In vitro evaluation of the effect of profound haemodilution with hydroxyethyl starch 6%, modified fluid gelatin 4% and dextran 40 10% on coagulation profile measured by thromboelastography, Anaesthesia, 52, 1061, 10.1111/j.1365-2044.1997.220-az0354.x Wadei, 2006, Hepatorenal syndrome: pathophysiology and management, Clin J Am Soc Nephrol, 1, 1066, 10.2215/CJN.01340406 Kaw, 2006, Platelet dysfunction and end-stage renal disease, Semin Dial, 19, 317, 10.1111/j.1525-139X.2006.00179.x Boccardo, 2004, Platelet dysfunction in renal failure, Semin Thromb Hemost, 30, 579, 10.1055/s-2004-835678 Mezzano, 1996, Hemostatic disorder of uremia: the platelet defect, the main determinant of prolonged bleeding time, is correlated with indices of activation of coagulation and fibrinolysis, Thromb Haemost, 76, 312, 10.1055/s-0038-1650576 Escolar, 1991, Abnormal cytoskeletal assembly in platelets from uremic patients, Am J Pathol, 143, 823 Segal, 2005, Paucity of studies to support that abnormal coagulation test results predict bleeding in the setting of invasive procedures, Transfusion, 45, 1413, 10.1111/j.1537-2995.2005.00546.x Fisher, 1999, Central venous cannulation in patients with liver disease and coagulopathy—a prospective audit, Intensive Care Med, 25, 481, 10.1007/s001340050884 Foster, 1992, Central venous catheterization in patients with coagulopathy, Arch Surg, 127, 273, 10.1001/archsurg.1992.01420030035006 Doerfler, 1996, Central venous catheter placement in patients with disorders of hemostasis, Chest, 110, 185, 10.1378/chest.110.1.185 Wilson, 1990, A critical appraisal of coagulation studies prior to transfemoral angiography, Br J Radiol, 63, 147, 10.1259/0007-1285-63-746-147 Darcy, 1996, Evaluation of coagulation tests as predictors of angiographic bleeding, Radiology, 198, 741, 10.1148/radiology.198.3.8628863 MacDonald, 2003, A comparison of arterial closure devices to manual compression in liver transplantation candidates undergoing coronary angiography, J Invasive Cardiol, 15, 1568 Faybik, 2006, Molecular adsorbent recirculating system and hemostasis in patients at high risk of bleeding: an observational study, Crit Care, 10, R24, 10.1186/cc3985 Northup, 2008, Hypercoagulation and thrombophilia in liver disease, J Thromb Haemost, 6, 2 Fischer, 2007, Essentials of anticoagulation in hemodialysis, Hemodial Int, 11, 178, 10.1111/j.1542-4758.2007.00166.x Vargas Hein, 2004, Anticoagulation in continuous renal replacement therapy, Contrib Nephrol, 144, 308, 10.1159/000078898 Hofbauer, 1999, Effect of anticoagulation on blood membrane interactions during hemodialysis, Kidney Int, 56, 1578, 10.1046/j.1523-1755.1999.00671.x Mitzner, 2001, Extracorporeal detoxification using the molecular adsorbent recirculating system for critically ill patients with liver failure, J Am Soc Nephrol, 12, S75, 10.1681/ASN.V12suppl_1s75 Rifai, 2003, Prometheus—a new extracorporeal system for the treatment of liver failure, J Hepatol, 39, 984, 10.1016/S0168-8278(03)00468-9 Rifai, 2007, Prometheus: from legend to the real liver support therapy, Int J Artif Organs, 30, 858, 10.1177/039139880703001002 Pryor, 2008, The promise of artificial liver replacement, Front Biosci, 13, 2140, 10.2741/2830 Ramos, 2003, Intraoperative red blood cell transfusion in liver transplantation: influence on patient outcome, prediction of requirements, and measures to reduce them, Liver Transpl, 9, 1320, 10.1016/jlts.2003.50204 Massicotte, 2006, Effect of low central venous pressure and phlebotomy on blood product transfusion requirements during liver transplantations, Liver Transpl, 12, 117, 10.1002/lt.20559